Maravai Lifesciences Correlations

MRVI Stock

USD 5.93 0.50 9.21%

The current 90-days correlation between Maravai Lifesciences and Roivant Sciences is 0.15 (i.e., Average diversification). The correlation of Maravai Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Maravai Lifesciences Correlation With Market

Average diversification

The correlation between Maravai Lifesciences Holdings and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Maravai Lifesciences Holdings and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Moving together with Maravai Stock

0.84	ME	23Andme Holding	Pair Corr
0.87	VALN	Valneva SE ADR	Pair Corr
0.8	ERNA	Eterna Therapeutics	Pair Corr
0.9	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.83	LLY	Eli Lilly	Pair Corr
0.85	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.94	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.62	TIL	Instil Bio	Pair Corr
0.73	GPCR	Structure Therapeutics	Pair Corr
0.66	INDP	Indaptus Therapeutics	Pair Corr
0.63	CINGW	Cingulate Warrants	Pair Corr
0.8	SXTPW	60 Degrees Pharmaceu	Pair Corr

Moving against Maravai Stock

0.88	BMY	Bristol Myers Squibb	Pair Corr
0.73	ESPR	Esperion Therapeutics	Pair Corr
0.65	IKT	Inhibikase Therapeutics	Pair Corr
0.6	XCUR	Exicure	Pair Corr
0.56	DYAI	Dyadic International	Pair Corr
0.43	OPK	Opko Health	Pair Corr
0.82	MNPR	Monopar Therapeutics	Pair Corr
0.76	MNMD	Mind Medicine	Pair Corr
0.73	GILD	Gilead Sciences	Pair Corr
0.32	MOLN	Molecular Partners	Pair Corr

Related Correlations Analysis

	ROIV	KRYS	RXDX	AKRO	APLS	HALO	AGIO	INSM	CERE	RARE
ROIV		0.71	0.21	0.12	0.68	-0.09	0.42	0.55	-0.04	-0.06	ROIV
KRYS	0.71		-0.06	0.09	0.71	0.22	0.5	0.49	0.02	-0.06	KRYS
RXDX	0.21	-0.06		0.75	-0.34	-0.63	0.52	-0.04	-0.16	-0.67	RXDX
AKRO	0.12	0.09	0.75		-0.34	-0.27	0.56	0.01	-0.1	-0.57	AKRO
APLS	0.68	0.71	-0.34	-0.34		0.28	0.2	0.38	-0.1	0.17	APLS
HALO	-0.09	0.22	-0.63	-0.27	0.28		-0.34	0.01	0.12	0.65	HALO
AGIO	0.42	0.5	0.52	0.56	0.2	-0.34		0.17	0.13	-0.74	AGIO
INSM	0.55	0.49	-0.04	0.01	0.38	0.01	0.17		0.07	0.24	INSM
CERE	-0.04	0.02	-0.16	-0.1	-0.1	0.12	0.13	0.07		0.1	CERE
RARE	-0.06	-0.06	-0.67	-0.57	0.17	0.65	-0.74	0.24	0.1		RARE
	ROIV	KRYS	RXDX	AKRO	APLS	HALO	AGIO	INSM	CERE	RARE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AKRO	+ 0.75	RXDX
KRYS	+ 0.71	ROIV
APLS	+ 0.71	KRYS
APLS	+ 0.68	ROIV
RARE	+ 0.65	HALO
AGIO	+ 0.56	AKRO

High negative correlations

RARE	- 0.74	AGIO
RARE	- 0.67	RXDX
HALO	- 0.63	RXDX
RARE	- 0.57	AKRO
AGIO	- 0.34	HALO
APLS	- 0.34	AKRO

Risk-Adjusted Indicators

There is a big difference between Maravai Stock performing well and Maravai Lifesciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Maravai Lifesciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ROIV	1.28	(0.14)	0.00	(0.06)	0.00	0.00	2.66	(2.52)	8.89
KRYS	1.82	(0.19)	(0.05)	0.00	2.18	(2.02)	4.45	(3.75)	12.22
RXDX	2.40	1.08	0.50	(2.43)	0.76	(2.61)	2.76	(3.26)	70.71
AKRO	2.48	0.05	0.05	0.14	2.75	(2.68)	5.23	(4.35)	13.37
APLS	2.46	(0.27)	0.00	(0.19)	0.00	0.00	4.57	(5.17)	15.91
HALO	2.26	(0.38)	0.00	(0.16)	0.00	0.00	3.90	(6.75)	28.41
AGIO	2.60	(0.16)	0.01	0.05	4.53	(2.53)	5.24	(5.08)	31.56
INSM	1.73	(0.15)	(0.03)	0.02	2.25	(1.73)	3.99	(3.49)	14.32
CERE	0.77	0.07	(0.04)	1.02	0.94	(1.02)	1.91	(1.59)	6.40
RARE	1.51	(0.25)	0.00	(0.32)	0.00	0.00	2.66	(3.20)	8.73

Maravai Lifesciences Corporate Management

Kurt Oreshack	General VP	Profile
Christine Dolan	Executive Technologies	Profile
Brian Neel	Chief Production	Profile
Peter Leddy	Executive Officer	Profile
Christopher Benoit	Executive Enzymes	Profile
Becky Buzzeo	Executive Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC